127 related articles for article (PubMed ID: 36326203)
21. Symptomatic Biliary Disorders During Lenvatinib Treatment for Thyroid Cancer: An Underestimated Problem.
Nervo A; Ragni A; Gallo M; Ferraris A; Fonio P; Piovesan A; Arvat E
Thyroid; 2020 Feb; 30(2):229-236. PubMed ID: 31854230
[No Abstract] [Full Text] [Related]
22. Thyroidectomy and parathyroid hormone: tracing hypocalcemia-prone patients.
Toniato A; Boschin IM; Piotto A; Pelizzo M; Sartori P
Am J Surg; 2008 Aug; 196(2):285-8. PubMed ID: 18466858
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis.
Hiraoka A; Kumada T; Atsukawa M; Hirooka M; Tsuji K; Ishikawa T; Takaguchi K; Kariyama K; Itobayashi E; Tajiri K; Shimada N; Shibata H; Ochi H; Tada T; Toyoda H; Nouso K; Tsutsui A; Nagano T; Itokawa N; Hayama K; Imai M; Joko K; Koizumi Y; Hiasa Y; Michitaka K; Kudo M;
Cancer Med; 2019 Jul; 8(8):3719-3728. PubMed ID: 31127698
[TBL] [Abstract][Full Text] [Related]
24. Parathyroid Changes After RAI in Patients With Differentiated Thyroid Carcinoma.
Xiao L; Zhang W; Zhu H; Wang Y; Liu B; Huang R; Li L
Front Endocrinol (Lausanne); 2021; 12():671787. PubMed ID: 34122347
[TBL] [Abstract][Full Text] [Related]
25. Teriparatide Therapy and Reduced Postoperative Hospitalization for Postsurgical Hypoparathyroidism.
Shah M; Bancos I; Thompson GB; Richards ML; Kasperbauer JL; Clarke BL; Drake MT; Stan MN
JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):822-7. PubMed ID: 26312597
[TBL] [Abstract][Full Text] [Related]
26. Predicting the need for calcium and calcitriol supplementation after total thyroidectomy: results of a prospective, randomized study.
Cayo AK; Yen TW; Misustin SM; Wall K; Wilson SD; Evans DB; Wang TS
Surgery; 2012 Dec; 152(6):1059-67. PubMed ID: 23068088
[TBL] [Abstract][Full Text] [Related]
27. Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer.
Reed N; Glen H; Gerrard G; Good J; Lei M; Lyon AR; Strachan M; Wadsley J; Newbold K
Clin Oncol (R Coll Radiol); 2020 May; 32(5):e145-e153. PubMed ID: 31843241
[TBL] [Abstract][Full Text] [Related]
28. Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5.
Dave V; Chiang CY; Booth J; Mount PF
Am J Nephrol; 2015; 41(2):129-37. PubMed ID: 25790847
[TBL] [Abstract][Full Text] [Related]
29. Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?
Tsvetov G; Amitai O; Shochat T; Shimon I; Akirov A; Diker-Cohen T
Osteoporos Int; 2020 Apr; 31(4):655-665. PubMed ID: 31838550
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of postthyroidectomy parathyroid hormone and corrected calcium levels as early predictors of clinical hypocalcemia.
Fahad Al-Dhahri S; Al-Ghonaim YA; Sulieman Terkawi A
J Otolaryngol Head Neck Surg; 2010 Aug; 39(4):342-8. PubMed ID: 20642997
[TBL] [Abstract][Full Text] [Related]
31. Prospective study of perioperative factors predicting hypocalcemia after thyroid and parathyroid surgery.
Chia SH; Weisman RA; Tieu D; Kelly C; Dillmann WH; Orloff LA
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):41-5. PubMed ID: 16415428
[TBL] [Abstract][Full Text] [Related]
32. Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
Iñiguez-Ariza NM; Ryder MM; Hilger CR; Bible KC
Thyroid; 2017 Jul; 27(7):923-927. PubMed ID: 28471306
[TBL] [Abstract][Full Text] [Related]
33. Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer.
Koehler VF; Berg E; Adam P; Weber GL; Pfestroff A; Luster M; Kutsch JM; Lapa C; Sandner B; Rayes N; Fuss CT; Kreissl MC; Hoster E; Allelein S; Schott M; Todica A; Fassnacht M; Kroiss M; Spitzweg C
Thyroid; 2021 Oct; 31(10):1531-1541. PubMed ID: 34405734
[No Abstract] [Full Text] [Related]
34. High Prevalence and Conservative Management of Acute Cholecystitis during Lenvatinib for Advanced Thyroid Cancer.
Di Stefano M; Colombo C; De Leo S; Perrino M; Viganò M; Persani L; Fugazzola L
Eur Thyroid J; 2021 Jul; 10(4):314-322. PubMed ID: 34395303
[TBL] [Abstract][Full Text] [Related]
35. A single-center experience of parathyroidectomy in 1500 cases for secondary hyperparathyroidism: a retrospective study.
Zhao S; Gan W; Xie W; Cao J; Zhang L; Wen P; Yang J; Xiong M
Ren Fail; 2022 Dec; 44(1):23-29. PubMed ID: 35094636
[TBL] [Abstract][Full Text] [Related]
36. Postoperative PTH monitoring of hypocalcemia expedites discharge after thyroidectomy.
Chow TL; Choi CY; Chiu AN
Am J Otolaryngol; 2014; 35(6):736-40. PubMed ID: 25091178
[TBL] [Abstract][Full Text] [Related]
37. PTH(1-34) for the Primary Prevention of Postthyroidectomy Hypocalcemia: The THYPOS Trial.
Palermo A; Mangiameli G; Tabacco G; Longo F; Pedone C; Briganti SI; Maggi D; Vescini F; Naciu A; Lauria Pantano A; Napoli N; Angeletti S; Pozzilli P; Crucitti P; Manfrini S
J Clin Endocrinol Metab; 2016 Nov; 101(11):4039-4045. PubMed ID: 27525532
[TBL] [Abstract][Full Text] [Related]
38. Validation of 1-hour post-thyroidectomy parathyroid hormone level in predicting hypocalcemia.
Le TN; Kerr PD; Sutherland DE; Lambert P
J Otolaryngol Head Neck Surg; 2014 Jan; 43(1):5. PubMed ID: 24476535
[TBL] [Abstract][Full Text] [Related]
39. The utility of serum PTH assessment 24 hours after total thyroidectomy.
Del Rio P; Arcuri MF; Ferreri G; Sommaruga L; Sianesi M
Otolaryngol Head Neck Surg; 2005 Apr; 132(4):584-6. PubMed ID: 15806050
[TBL] [Abstract][Full Text] [Related]
40. Low parathyroid hormone levels after thyroid surgery: a feasible predictor of hypocalcemia.
Lindblom P; Westerdahl J; Bergenfelz A
Surgery; 2002 May; 131(5):515-20. PubMed ID: 12019404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
